Research Area Articles

Cracking the Code of Skin Cancer Progression with VitroGel® Hydrogel Matrix

RESEARCH HIGHLIGHTS FROM THEWELL BIOSCIENCE Cracking the Code of Skin Cancer Progression with VitroGel® Hydrogel MatrixIn the recent blog post titled "Cracking the Code of Skin Cancer Progression with VitroGel® Hydrogel Matrix", TheWell Bioscience introduced an...

IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases

ARTICLE FROM KACTUS IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases In KACTUS ’s recent feature, Lauren He from KACTUS introduced a comprehensive overview of Interleukin-23 (IL-23) and its role in driving immune-mediated inflammatory...

Translational Continuity: Why Drug Programs Fail Early

ARTICLE BY BIO X CELLTranslational Continuity: Why Drug Programs Fail EarlyIn a recent blog post titled "Translational Continuity: Why Drug Programs Fail Early," Bio X Cell  introduced insights into why over 90% of drug candidates fail during clinical trials. A...

Mouse-Ready vs In Vivo-Ready Antibodies: Protecting Antibody Performance In Vivo

ARTICLE BY BIO X CELLFactors That Influence Antibody Performance In VivoBio X Cell has recently published an insightful guide titled “Factors That Influence Antibody Performance In Vivo,” addressing a critical hurdle in preclinical and translational research. As...